OTR Therapeutics News and Activities

Acquisition, funding and merger involving OTR Therapeutics.

• OTR Therapeutics has just announced a $100 Million fundraising (posted on December 8 2025).

View the org chart displaying its 5 main executives

Most searched biographies at OTR Therapeutics

• Zhui Chen, Chief Executive Officer
• Yuan Shi, Chief Scientific Officer
• Bing Yu, Executive Director

Create your alert
to follow the executive moves at OTR Therapeutics.

OTR Therapeutics has 2,426 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• The new name of ChemoTech is Neem’s Hill. (posted on July 14 2026).
• MindRank has just announced a $52 Million fundraising (posted on July 14 2026).
• Chemomab and Scipher Medicine have announced they will merge  (posted on July 13 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by OTR Therapeutics

Social media about OTR Therapeutics

• OTR Therapeutics on Wikipedia, Google News & Yahoo Finance
• OTR Therapeutics on LinkedIn, X (Twitter) & YouTube